Cyclosporine Ophthalmic Nanoemulsion employs unique nanoparticle technology to increase tear production in patients with keratoconjunctivitis sicca-related ocular inflammatory disease, offering faster symptom relief for those with suppressed tear formation
Read MoreSubscribe to our newsletter to get updates on our latest news